Effects of melatonin on rat pial arteriolar diameter in vivo
Effects of melatonin on rat pial arteriolar diameter in vivo
复制标题
DOI:
10.1038/sj.bjp.0702714
复制
发表时间:
1999-08
影响因子:
7.3
通讯作者:
O. Régrigny;P. Delagrange;E. Scalbert;I. Lartaud‐Idjouadiene;J. Atkinson;J. Chillon
中科院分区:
文献类型:
--
作者:
O. Régrigny;P. Delagrange;E. Scalbert;I. Lartaud‐Idjouadiene;J. Atkinson;J. Chillon
Based on our finding that melatonin decreased the lower limit of cerebral blood flow autoregulation in rat, we previously suggested that melatonin constricts cerebral arterioles. The goal of this study was to demonstrate this vasoconstrictor action and investigate the mechanisms involved.The effects of cumulative doses of melatonin (10−10to 10−6M) were examined in cerebral arterioles (30–50 μM) of male Wistar rats using an open skull preparation. Cerebral arterioles were exposed to two doses of melatonin (3×10−9and 3×10−8M) in the absence and presence of the mt1and/or MT2receptor antagonist, luzindole (2×10−6M) and the Ca2+‐activated K+(BKCa) channel blocker, tetraethylammonium (TEA+, 10−4M). The effect ofL‐nitro arginine methyl ester (L‐NAME, 10−8M) was examined on arterioles after TEA+superfusion. Cerebral arterioles were also exposed to the BKCaactivator, NS1619 (10−5M), and to sodium nitroprusside (SNP, 10−8M) in the absence and presence of melatonin (3×10−8M).Melatonin induced a dose‐dependent constriction with an EC50of 3.0±0.1 nMand a maximal constriction of −15±1%. Luzindole abolished melatonin‐induced vasoconstriction. TEA+induced significant vasoconstriction (−10±2%). No additional vasoconstriction was observed when melatonin was added to the aCSF in presence of TEA+, whereasL‐NAME still induced vasoconstriction (−10±1%). NS1619 induced vasodilatation (+11±1%) which was 50% less in presence of melatonin. Vasodilatation induced by SNP (+12±2%) was not diminished by melatonin.Melatonin directly constricts small diameter cerebral arterioles in rats. This vasoconstrictor effect is mediated by inhibition of BKCachannels following activation of mt1and/or MT2receptors.British Journal of Pharmacology(1999)127, 1666–1670; doi:10.1038/sj.bjp.0702714